Keb Asset Management LLC Invests $1.01 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Keb Asset Management LLC acquired 1,934 shares of UnitedHealth Group (NYSE:UNH), valued at approximately $1,013,000, during the first quarter.
• UnitedHealth Group's CEO sold 589 shares for about $179,645, revealing a 5.36% decrease in his ownership, while a director increased their stake by 34.07% with a purchase of 1,533 shares.
• The company's recent quarterly earnings showed an earnings per share (EPS) of $4.08, missing analysts' expectations of $4.45, with revenues of $111.62 billion, slightly short of the anticipated $111.75 billion.

Keb Asset Management LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 1,934 shares of the healthcare conglomerate's stock, valued at approximately $1,013,000.

Other institutional investors have also modified their holdings of the company. Brighton Jones LLC grew its position in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC raised its holdings in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after buying an additional 2,324 shares during the last quarter. Bank Pictet & Cie Europe AG increased its position in UnitedHealth Group by 3.9% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock valued at $133,373,000 after acquiring an additional 9,872 shares during the period. Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group during the 4th quarter worth $30,000. Finally, Azimuth Capital Investment Management LLC lifted its holdings in UnitedHealth Group by 1.1% in the fourth quarter. Azimuth Capital Investment Management LLC now owns 53,866 shares of the healthcare conglomerate's stock worth $27,249,000 after purchasing an additional 561 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. JPMorgan Chase & Co. reduced their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research note on Wednesday. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Oppenheimer dropped their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Finally, Hsbc Global Res cut UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. Three analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $366.52.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil acquired 3,700 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director owned 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction on Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director directly owned 6,033 shares of the company's stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock worth $31,607,768 over the last quarter. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Down 0.6%

Shares of UNH stock traded down $1.37 during trading on Thursday, hitting $244.42. 11,331,473 shares of the company were exchanged, compared to its average volume of 18,403,832. The firm has a market capitalization of $221.72 billion, a price-to-earnings ratio of 10.59, a P/E/G ratio of 1.59 and a beta of 0.43. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The business's 50-day simple moving average is $292.78 and its 200 day simple moving average is $408.71. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the company posted $6.80 earnings per share. The company's revenue was up 12.9% compared to the same quarter last year. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 3.6%. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.